| 000 | 01865cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030820.0 | ||
| 008 | 130408s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2012.Em.S | ||
| 100 | 0 | _aEman Ahmed Rashed | |
| 245 | 1 | 0 |
_aSerum selenium and serum lipoprotein subfractions in type 2 diabetic patients / _cEman Ahmed Rashed ; Supervised Dina Farouk Elgayar , Dina Mohamed Elabd , Ashraf Ismail Amin |
| 246 | 1 | 5 | _aمستوى السيلنيوم فى المصل ومستوى مكونات البروتينات الدهنية فى المصل فى مرضى البول السكرى النوع الثانى |
| 260 |
_aCairo : _bEman Ahmed Rashed , _c2012 |
||
| 300 |
_a146P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _a Type 2 Diabetic Mellitus (DM) is rapidly rising as a global health care problem that is threatening to reach pandemic levels by 2030 . Type 2 MD is the leading cause of blindness , non traumatic lower limb amputation and chronic kidney disease in the United States . It is a major cause of cardiovascular disease leading to early death . The increasing incidence of type 2 MD is largely attributable to changes in life style (diet and activity level) and obesity | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aApolipoprotein | |
| 653 | 4 | _aCholesterol esterase | |
| 653 | 4 | _aDiabetes Mellitus | |
| 700 | 0 |
_aAshraf Ismail Amin , _eSupervisor |
|
| 700 | 0 |
_aDina Farouk Elgayar , _eSupervisor |
|
| 700 | 0 |
_aDina Mohamed Elabd , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42521 _d42521 |
||